UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 8, 2023
Accession Number:
0001493152-23-006694
Submission Type:
POS AM
CIK:
0001849296
Company Name:
OKYO Pharma Ltd
File Number:
333-268675